IENTILE, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 341
EU - Europa 332
AS - Asia 53
Continente sconosciuto - Info sul continente non disponibili 1
Totale 727
Nazione #
US - Stati Uniti d'America 341
IE - Irlanda 133
SE - Svezia 91
PL - Polonia 40
IT - Italia 38
CN - Cina 35
DE - Germania 16
SG - Singapore 12
RO - Romania 8
VN - Vietnam 4
FI - Finlandia 2
FR - Francia 2
IN - India 2
UA - Ucraina 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 727
Città #
Chandler 134
Dublin 133
Nyköping 59
Warsaw 40
Ashburn 32
Messina 19
Princeton 17
Bremen 15
Medford 15
Dearborn 8
Des Moines 8
Falls Church 8
Focsani 8
Singapore 7
Wilmington 6
Beijing 5
Jacksonville 5
New York 5
Boardman 4
Dong Ket 4
Jinan 4
Shenyang 4
Tianjin 4
Washington 4
Cambridge 2
Caserta 2
Catania 2
Dalmine 2
Ningbo 2
Rome 2
Chengdu 1
Chicago 1
Cormano 1
Cosenza 1
Dalian 1
Fairfield 1
Fuzhou 1
Guangzhou 1
Hangzhou 1
Helsinki 1
Lanzhou 1
Lappeenranta 1
Los Angeles 1
Lviv 1
Munich 1
Nanchang 1
Nanjing 1
Poltava 1
Pune 1
Qingdao 1
San Mateo 1
Seattle 1
Taizhou 1
Zhengzhou 1
Totale 584
Nome #
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study 102
Gender differences in outpatient pediatric drug utilization: A cohort study from southern Italy 65
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? 65
How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016 47
Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy 45
In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study 43
Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy 43
Real world use of antidiabetic drugs in the years 2011–2017: A population-based study from Southern Italy 43
Overview of the Safety of Anti-VEGF Drugs: Analysis of the Italian Spontaneous Reporting System 42
Real world use of biological drugs in patients with psoriasis/psoriatic arthritis: a retrospective, population-based study from Southern Italy in the years 2010-2014 42
Safety profile of immune checkpoint inhibitors: An analysis of the Italian spontaneous reporting system database 41
Gender differences in COPD management in a Sicilian general practice setting: a cohort study evaluating the impact of educational interventions 38
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project 37
Characteristics and Absolute Survival of Metastatic Colorectal Cancer Patients Treated With Biologics: A Real-World Data Analysis From Three European Countries 34
Improvement in the management of chronic obstructive pulmonary disease following a clinical educational program: results from a prospective cohort study in the Sicilian general practice setting 26
null 22
null 16
IDENTIFICAZIONE DI FATTORI PREDITTIVI DI BASSO DOSAGGIO DI NUOVI ANTICOAGULANTI ORALI: UNO STUDIO DI POPOLAZIONE NELL’ASP DI PALERMO 10
Development and testing of diagnostic algorithms to identify patients with acromegaly in Southern Italian claims databases 4
Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy 2
Totale 767
Categoria #
all - tutte 3.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035 0 0 0 1 1 7 1 0 2 3 2 18
2020/202186 2 4 12 17 13 7 8 6 9 4 0 4
2021/2022145 0 14 0 1 5 5 17 2 20 28 7 46
2022/2023393 23 47 14 46 32 36 1 25 154 1 8 6
2023/202489 8 10 5 16 4 28 1 4 0 3 2 8
2024/202511 6 5 0 0 0 0 0 0 0 0 0 0
Totale 767